Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot randomized placebo-controlled trial of inhaled tobramycin in non-cystic fibrosis bronchiectasis with intermittent Pseudomonas aeruginosa infection
2005-005820-15Phase 4Completed
- Sponsor
- Vall d'Hebron University Hospital
- Start
- Jul 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in bronchiectasis and Pseudomonal infection comparing Inhaled tobramycin with Placebo (2 arms). Primary endpoint: Presence of Pseudomonas aeruginosa in sputum. Started Jul 2006; status: completed.
02
Drugs
tobramycin
03
Conditions
bronchiectasisPseudomonal infection
Beyond the preview
Go deeper on 2005-005820-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005820-15.